Abstract
The Real-Life Safety and Efficacy of vardenafil study is an international, open-label, prospective, noncomparative, noninterventional study in men with erectile dysfunction (ED). To determine the safety and efficacy of vardenafil in a large international pool of men with ED (aged ≥ 18 years) and associated underlying conditions (N=73,946), in a real-life setting. Patients attended an initial physician visit and one to two follow-up visits. Data were acquired by physician interviews and patient diaries and recorded in case report forms (CRFs). Data were pooled from 47 countries in Europe, Asia-Pacific, Latin America, and the rest of the world (excluding the United States and Japan for methodological reasons). Results were stratified by baseline ED severity, body mass index (BMI), and the presence of hypertension, diabetes, lipid metabolism disorder, or cardiovascular disease (CVD). CRFs and patient questionnaires containing questions on overall improvement of erection, satisfaction with efficacy, and desire to continue vardenafil use. Many participants had hypertension (32.0%), diabetes (22.1%), lipid metabolism disorder (14.6%), or CVD (42.2%). High percentages of patients reported improvements in erectile function, irrespectiv...Continue Reading
References
Jul 7, 1993·JAMA : the Journal of the American Medical Association
Aug 12, 1999·BJU International·I A AytaR J Krane
Mar 25, 2000·Preventive Medicine·H A FeldmanJ B McKinlay
Jun 21, 2001·International Journal of Impotence Research·M BraunU Engelmann
Mar 1, 2003·Diabetes Care·Irwin GoldsteinUNKNOWN Vardenafil Diabetes Study Group
Aug 30, 2003·Urology·Hartmut PorstUNKNOWN International Vardenafil Study Group
Apr 15, 2004·European Urology·Dimitrios HatzichristouUNKNOWN European Vardenafil Study Group
Dec 15, 2004·Urology·François A GiulianoAnne Solesse de Gendre
Jan 21, 2006·The Journal of Sexual Medicine·Hermann van AhlenMarcus Neureither
Nov 8, 2006·The Journal of Sexual Medicine·Eric Cheng
Feb 9, 2007·International Journal of Impotence Research·C M KimUNKNOWN Korea Post-Marketing Surveillance Research Group
Apr 25, 2007·Clinical Drug Investigation·A KamelH Landen
Jun 5, 2007·Endocrinology and Metabolism Clinics of North America·André T Guay
Apr 1, 2008·The Journal of Sexual Medicine·Martin MinerAllison Barnes
Apr 9, 2008·European Urology·Jurgen ZumbéErnst Ulbrich
May 24, 2008·Journal of the American College of Cardiology·Ronald Ching-Wan MaPeter Chun-Yip Tong
Sep 3, 2008·The Journal of Sexual Medicine·Ee Ming KhooWah Yun Low
Jan 10, 2009·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Elena Lopez-GonzalezAdolfo Figueiras
Feb 3, 2009·Mayo Clinic Proceedings·Brant A InmanSteven J Jacobsen
Jan 8, 2010·Clinical Interventions in Aging·Antonio Martín MoralesPierre Costa
Citations
Apr 3, 2013·Archives of Sexual Behavior·Sabina SarinYitzchak M Binik
Jan 11, 2014·Current Cardiology Reports·Richard A Lange, Glenn N Levine
Oct 15, 2011·The Journal of Sexual Medicine·Shiu-Dong ChungHerng-Ching Lin
Aug 4, 2011·The Journal of Sexual Medicine·Shiu-Dong ChungHerng-Ching Lin
Dec 15, 2010·The Journal of Sexual Medicine·Zdravko Asenov Kamenov
Apr 6, 2016·The Journal of Sexual Medicine·Konstantinos HatzimouratidisMohit Khera
May 7, 2016·Sexual Medicine·Ridwan ShabsighUNKNOWN REVITALISE Study Group
Jul 1, 2014·International Journal of Endocrinology·Andrea M IsidoriUNKNOWN SIAMS-ED Study Group
Jan 24, 2012·Circulation·Glenn N LevineUNKNOWN Council on Quality of Care and Outcomes Research
Oct 15, 2014·International Journal of Clinical Practice·J C HsuC Y Lu
Feb 20, 2020·Journal of Hypertension·Margus ViigimaaUNKNOWN European Society of Hypertension Working Group on Sexual Dysfunction
Jan 9, 2014·The Aging Male : the Official Journal of the International Society for the Study of the Aging Male·Uwe HartmannAndreas Mattern
Apr 15, 2020·Current Vascular Pharmacology·Konstantinos ImprialosMichael Doumas